BackL1 vs L2

L1 vs L2

Binance
2026-06-30 23:01:05

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration

In a comprehensive interview with Galaxy, Binance founder CZ shares his views on market cycles, the convergence of crypto and traditional finance, decentralization, Layer 2 vs Layer 1, Hyperliquid's innovation, prediction markets like Polymarket, and his personal investment philosophy. He believes the current cycle bottom is significantly higher than previous lows (BTC support around $60k), and industry leverage is better controlled. Crypto and TradFi will inevitably merge, with centralization and decentralization coexisting. CZ reveals Yzi Labs' investment heuristic: 70% crypto, 20% AI, 10% biotech, including investments in an artificial womb company (tested on mice, human application 5-10 years away) and knee cartilage regeneration technology (3D-printed scaffold). He also compares Chinese and US AI models, emphasizing that AI regulation is far more complex than crypto, and that the future financial system will be built collaboratively by AI, blockchain, and the internet.

470
CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration
CZ
2026-06-30 19:31:09

CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech — Market Cycles, Centralization vs Decentralization, Prediction Markets, and Vision for the Future

In an extensive interview with Galaxy, CZ shared his macro outlook on the crypto market: the current drawdown of ~50% is normal, but each cycle's floor is higher, with historical highs (e.g., $60,000) likely acting as future support. He sees inevitable convergence between crypto and traditional finance into one fintech sector, and that centralization and decentralization will coexist indefinitely, with technology pushing toward the latter. CZ praised Hyperliquid for carving out a niche Binance cannot compete in, and backed prediction markets like Polymarket and Kalshi. He disclosed Yzi Labs' portfolio allocation: 70% crypto, 20% AI, 10% biotech, notable bets include an "artificial womb" (tested on mice, 5-10 years from human use) and a knee cartilage regeneration technology using 3D-printed scaffolds. He stressed that investment aims for impact over ROI, and warned that AI poses existential risks far greater than crypto, urging careful regulation.

310
CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech — Market Cycles, Centralization vs Decentralization, Prediction Markets, and Vision for the Future
CZ
2026-06-30 15:01:04

CZ on Crypto Cycles, Portfolio Strategy, and the AI Future: 70% Crypto, 20% AI, 10% Biotech

In a detailed interview with Galaxy, Binance founder Changpeng Zhao (CZ) shared his macro outlook on the crypto market, emphasizing that the four-year cycle continues with rising bottoms and healthier leverage among institutions. He revealed Yzi Labs' investment allocation: 70% crypto, 20% AI, 10% biotech, with bets on startups developing artificial wombs and knee cartilage regeneration. CZ also discussed the convergence of crypto and traditional finance, the role of perpetuals and prediction markets, the L1 vs L2 debate, and his belief that while AI could pose existential risks, it will ultimately rely on blockchain infrastructure.

350
CZ on Crypto Cycles, Portfolio Strategy, and the AI Future: 70% Crypto, 20% AI, 10% Biotech
CZ
2026-06-27 14:31:02

CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech – Investments in Artificial Womb and Knee Regeneration, Market Cycle Outlook

In a comprehensive interview with Galaxy, Binance founder CZ shares his views on the current crypto market: Bitcoin's 50% drawdown is normal but bottoms are rising, with $60,000 as a key support. He predicts inevitable convergence of crypto and traditional finance, coexistence of centralization and decentralization. His investment portfolio is allocated 70% crypto, 20% AI, 10% biotech, including an artificial womb startup (tested on mice) and a knee cartilage regeneration project (human clinical trials). He praises Hyperliquid and prediction markets (Polymarket), discusses L1 vs L2 dynamics, and emphasizes AI's future role in driving crypto adoption while warning about AI risks to civilization.

280
CZ Deep Dive: 70% Crypto, 20% AI, 10% Biotech – Investments in Artificial Womb and Knee Regeneration, Market Cycle Outlook